 at
side effects using air and CO2 foam for endovenous
chemical ablation and found visual disturbances (VDs)
were experienced by 3.1% (4/128) and 8.2% (4/49) patients
in the CO2 and room air groups respectively (P ¼ .15). Respiratory difﬁculties or circumoral paresthesia each
occurred in 0.8% (n ¼ 